Summarized by Masters of Longevity from TechCrunch.
Startup raised $400 million and will expand trials of its PRIMA device.

Key Takeaways
- Science Corporation raised $400 million in a Series D.
- PRIMA is approved in Europe and used in Germany.
- US use via FDA Humanitarian Device Exemption is planned.



